Peninsula medical device maker refiles IPO, while eye drug company seeks $86M public market debut

Two Redwood City life sciences companies filed for IPOs — one resubmitting paperwork after withdrawing its initial public offering in May and the other trying to push a drug for blinding eye diseases toward a late-stage clinical trial. Medical device maker Pulmonx Corp. and eye disease drug maker Graybug Vision Inc. came amid of flurry of Friday filings for initial public offerings. Pulmonx, which initially filed its IPO in February, said it plans to use proceeds of its IPO to hire more sales…